TITLE:
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
sitagliptin (MK0431)

SUMMARY:

      The purpose of this investigational study is to determine the safety and effectiveness of an
      investigational drug in patients with type 2 diabetes mellitus (a specific type of
      diabetes).
    

DETAILED DESCRIPTION:

      The duration of treatment is 104 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 78 Years
Criteria:

        Inclusion Criteria:

          -  Patients who are at least 18 years of age and not older than 78 with type 2 diabetes
             mellitus
      
